B

Biohit Oyj
OMXH:BIOBV

Watchlist Manager
Biohit Oyj
OMXH:BIOBV
Watchlist
Price: 2.57 EUR -3.49% Market Closed
Market Cap: 38.8m EUR
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one BIOBV stock under the Base Case scenario is 3.83 EUR. Compared to the current market price of 2.57 EUR, Biohit Oyj is Undervalued by 33%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BIOBV Relative Value
Base Case
3.83 EUR
Undervaluation 33%
Relative Value
Price
B
Worst Case
Base Case
Best Case

Valuation Multiples

2.7
P/S
P/S
Price to Sales
2.7
vs History
46
vs Industry
37
Median 3Y
2.4
Median 5Y
2.7
Industry
2.1
Forward
2.2
More Details
15.2
P/E
P/E
Price to Earnings
15.2
vs History
52
vs Industry
31
Median 3Y
21.4
Median 5Y
15.6
Industry
21.5
Forward
16.7
More Details
66.6
P/OCF
P/OCF
Price to OCF
66.6
vs History
14
vs Industry
3
Median 3Y
24
Median 5Y
13.8
Industry
13.2
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
1
Median 3Y
-29.8
Median 5Y
-52.8
Industry
18.8
More Details
3.2
P/B
P/B
Price to Book Value
3.2
vs History
58
vs Industry
24
Median 3Y
3.2
Median 5Y
3.3
Industry
2
More Details
2.3
EV/S
EV/S
Enterprise Value to Sales
2.3
vs History
46
vs Industry
41
Median 3Y
2
Median 5Y
2.2
Industry
2.2
Forward
1.9
More Details
3.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.5
vs History
49
vs Industry
49
Median 3Y
3.1
Median 5Y
3.5
Industry
4.6
More Details
11.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
11.3
vs History
47
vs Industry
27
Median 3Y
12.8
Median 5Y
11.2
Industry
11.4
Forward
10.6
More Details
12.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
12.8
vs History
42
vs Industry
31
Median 3Y
16.4
Median 5Y
12.3
Industry
15.4
Forward
10.6
More Details
55.7
EV/OCF
EV/OCF
Enterprise Value to OCF
55.7
vs History
12
vs Industry
4
Median 3Y
18.8
Median 5Y
10.8
Industry
13
More Details
177.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
177.4
vs History
11
vs Industry
2
Median 3Y
18.8
Median 5Y
11.2
Industry
16.5
More Details
4
EV/IC
EV/IC
Enterprise Value to IC
4
vs History
61
vs Industry
18
Median 3Y
4
Median 5Y
4.5
Industry
1.8
More Details

Multiples Across Competitors

BIOBV Competitors Multiples
Biohit Oyj Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
FI
Biohit Oyj
OMXH:BIOBV
39m EUR 2.7 15.2 11.3 12.8
US
Abbott Laboratories
NYSE:ABT
219.7B USD 5.2 16.4 22 32.1
US
Intuitive Surgical Inc
NASDAQ:ISRG
175.8B USD 21 75.7 58.7 71.1
US
Boston Scientific Corp
NYSE:BSX
138B USD 8.2 74.5 34.1 48.2
US
Stryker Corp
NYSE:SYK
133.6B USD 5.9 44.6 23.2 28
IE
Medtronic PLC
NYSE:MDT
106.4B USD 3.2 25 13.4 18.9
US
Becton Dickinson and Co
NYSE:BDX
58.5B USD 2.8 33.5 14.3 25.8
DE
Siemens Healthineers AG
XETRA:SHL
48.7B EUR 2.1 24.5 14.4 20.5
US
Edwards Lifesciences Corp
NYSE:EW
40.8B USD 7.5 9.8 22.9 25.3
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
263.1B CNY 7.1 21.2 18.4 18.4
US
IDEXX Laboratories Inc
NASDAQ:IDXX
31.9B USD 8.2 35.9 25.6 28.5

See Also

Summary
BIOBV intrinsic value, competitors valuation, and company profile.
DCF Valuation
BIOBV stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BIOBV stock valuation using valuation multiples.
Wall Street Estimates
BIOBV price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BIOBV stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 246,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.